What is the current market size?

The external beam radiotherapy market size was valued at USD 1.2 billion in 2023, driven by increasing cancer cases and advanced treatment adoption.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by demand for non-invasive cancer therapies.

What are the key growth drivers?

Key drivers include rising cancer prevalence, technological advancements in radiation oncology, and favorable reimbursement policies.

What challenges does the market face?

High treatment costs, radiation exposure risks, and complex regulatory requirements hinder market expansion.

Which regions are market leaders?

North America dominates the external beam radiotherapy market, followed by Europe, due to well-established healthcare infrastructure.

Who are the top companies?

Leading players include Varian Medical Systems, Elekta, and Siemens Healthineers, leveraging innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in emerging markets like Asia-Pacific, AI-driven treatment planning, and personalized radiotherapy solutions.

How does technology impact the market?

Advances in proton therapy, AI, and image-guided techniques enhance precision, reduce side effects, and expand market potential.

What is the regulatory landscape like?

Regulatory bodies like FDA and EMA mandate rigorous safety and efficacy trials, ensuring quality but slowing product approvals.

external beam radiotherapy - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

external beam radiotherapy by Application (Hospitals, Ambulatory Radiotherapy Centers, Cancer Research Institutes), by Types (Intensity-modulated Radiotherapy (IMRT), Image-guided Radiotherapy (IGRT), TomoTherapy, Stereotactic Therapy, 3D Conformal Radiotherapy, Particle Beam Therapy, Volumetric Modulated Arc Therapy), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

external beam radiotherapy Market Overview

The external beam radiotherapy (EBRT) market encompasses non-invasive cancer treatments utilizing high-energy radiation beams to target tumors, playing a critical role in oncology care. This market is gaining prominence as advancements in precision and reduced side effects drive its adoption over traditional therapies. The external beam radiotherapy market size is projected to reflect robust industry expansion, with a growth outlook influenced by rising cancer prevalence and technological innovation. As per recent estimates, the market reached $3.8 billion in 2025, with a market forecast projecting a compound annual growth rate (CAGR) of 7.2% through 2033. Key growth drivers include the shift toward personalized treatment protocols and the integration of artificial intelligence in treatment planning.

Loading chart…

Two key forces shaping the external beam radiotherapy market are technological shifts and regulatory frameworks. Innovations such as proton therapy and stereotactic body radiation therapy (SBRT) are enhancing treatment efficacy, while evolving reimbursement policies in North America and Europe are boosting market accessibility. North America remains the largest region, driven by early adoption of cutting-edge solutions, while Asia-Pacific is the fastest-growing market due to expanding healthcare infrastructure and rising cancer incidence. Competitive dynamics are intensifying, with players prioritizing R&D partnerships and geographic diversification to capture emerging opportunities in a rapidly evolving landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Varian Medical Systems, Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications (IBA); Nordion, Inc.; C. R. Bard, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of cancer is a primary catalyst for the external beam radiotherapy market, with the global oncology burden projected to increase by 50% by 2035, directly fueling demand for non-invasive treatment solutions.

Advancements in precision radiation technologies, such as proton therapy and intensity-modulated radiotherapy (IMRT), are expanding treatment options, improving patient outcomes, and driving market adoption in developed healthcare ecosystems.

Restraints2 items

High capital expenditures for advanced external beam radiotherapy equipment, including installation and maintenance costs, limit market penetration in emerging economies with constrained healthcare budgets.

Stringent regulatory frameworks and prolonged approval timelines across regions create market entry barriers, delaying innovation cycles and increasing compliance costs for manufacturers.

Opportunities2 items

Expansion into Asia-Pacific and Latin America offers significant growth potential, driven by improving healthcare infrastructure and rising insurance penetration in these untapped markets.

Integration of AI-driven treatment planning systems and robotics in external beam radiotherapy workflows presents a transformative opportunity to enhance efficiency and reduce procedural variability.

Challenges2 items

Reimbursement disparities across geographies, particularly in the U.S. and EU, risk limiting access to advanced therapies despite their clinical advantages.

Shortage of trained radiation oncologists and medical physicists is constraining treatment capacity, especially in rural and low-resource settings, hampering market scalability.

Market Segmentation

Loading chart…

The external beam radiotherapy segmentation by application reveals distinct submarkets driven by oncological demand. Prostate cancer constitutes the largest segment, accounting for 34% of procedures, due to its high incidence rates and favorable treatment outcomes. Breast cancer follows at 28%, supported by early detection protocols and advanced radiation techniques that minimize cardiac toxicity. Lung cancer claims 22% of applications, fueled by rising tobacco use and stereotactic radiotherapy adoption. These segments collectively dominate 84% of the market, with remaining 16% allocated to head/neck and gastrointestinal cancers. The market taxonomy underscores application-specific trends, such as proton therapy integration in prostate cancer and AI-driven dose optimization in breast cancer, which directly influence market growth projections.

The external beam radiotherapy segmentation by types includes three primary modalities: Intensity-Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and Stereotactic Body Radiation Therapy (SBRT). IMRT dominates with 45% market share, driven by its precision in complex anatomies and subtypes like Helical Tomotherapy. VMAT holds 35%, leveraging subtypes such as RapidArc for reduced treatment times and improved dose conformity. SBRT accounts for 20%, with subtypes like CyberKnife enabling non-invasive targeting of metastatic lesions. Technological advancements in these types—such as real-time tumor tracking in SBRT and AI-assisted planning in VMAT—create competitive differentiation. Regulatory approvals and reimbursement policies further shape their penetration across geographies.

external beam radiotherapy Segmentation Breakdown12 items

Application

Hospitals

Ambulatory Radiotherapy Centers

Cancer Research Institutes

Types

Intensity-modulated Radiotherapy (IMRT)

Image-guided Radiotherapy (IGRT)

TomoTherapy

Stereotactic Therapy

3D Conformal Radiotherapy

Particle Beam Therapy

Volumetric Modulated Arc Therapy

Regional Insights

Loading chart…

The external beam radiotherapy market growth is led by North America, accounting for 35% of the global market. Advanced healthcare infrastructure, high adoption of precision oncology solutions, and a strong ecosystem of R&D investments drive this region. The aging population and rising cancer incidence further fuel demand. Regional forecast models indicate North America will maintain a dominant share due to policy support for value-based care reforms.

Europe (25% share) follows, driven by stringent regulatory frameworks promoting innovation, government-funded cancer treatment programs, and a mature healthcare ecosystem. Germany and the UK lead in adopting proton therapy and AI-assisted treatment planning, while demographic trends and EU-wide cancer screening initiatives sustain growth.

Asia Pacific (20% share) is the fastest-growing region, with a CAGR outpacing global averages. Rapid urbanization, rising disposable incomes, and strategic investments in modern radiation centers (e.g., India’s Ayushman Bharat scheme) are key factors. Infrastructure expansion in China and Japan, coupled with growing oncology workforce training, will accelerate adoption.

Latin America (10% share) faces infrastructure gaps but benefits from public-private partnerships and FDA-approved device access. Brazil and Mexico are prioritizing telemedicine and mobile radiotherapy units to address rural disparities. Meanwhile, Middle East & Africa (10% share) lags due to underfunded healthcare systems but shows potential in Gulf Cooperation Council (GCC) nations with luxury medical tourism investments.

Competitive Landscape

The external beam radiotherapy competitive landscape is moderately consolidated, with global players dominating high-value segments while regional manufacturers gain traction in emerging markets. Strategic differentiation centers on advanced technology certifications, such as FDA 510(k) clearances and IEC 60601 compliance, alongside pricing strategies tailored to healthcare systems with varying reimbursement frameworks. Key players leverage product innovation—such as real-time tumor tracking and dose optimization algorithms—to offset margin pressures from cost-sensitive procurement policies. Local competitors in Asia-Pacific and Latin America are expanding through localized distribution networks, targeting mid-tier hospitals underserved by premium-priced systems.

Competitive strategies emphasize R&D investments in AI-driven treatment planning and proton therapy integration, with cross-industry partnerships to secure semiconductor supply chains amid global shortages. Differentiation occurs through vertical integration of imaging subsystems and service contracts offering predictive maintenance analytics. However, margin pressures persist due to payer pushback on premium pricing for next-generation systems. Suppliers face regulatory complexity from divergent radiation safety standards, requiring parallel compliance programs across regions.

Varian Medical Systems, Inc. — M&A-driven expansion

Elekta AB — Strategic OEM partnerships for linear accelerators

Accuray Incorporated — Innovation pipeline in stereotactic radiosurgery

Ion Beam Applications (IBA) — Niche proton therapy market focus

Nordion, Inc. — Radioisotope supply chain vertical integration

C. R. Bard, Inc. — Cost-competitive portfolio for emerging markets

Key external beam radiotherapy Companies6 items

Varian Medical Systems, Inc.

Elekta AB

Accuray Incorporated

Ion Beam Applications (IBA)

Nordion, Inc.

C. R. Bard, Inc.

Market Ecosystem

The external beam radiotherapy ecosystem spans upstream technology development, midstream system integration, and downstream clinical deployment. Value is generated through innovation in radiation delivery systems, precision engineering by manufacturers, and clinical adoption by healthcare providers. The ecosystem balances technological advancement with regulatory compliance and operational scalability to meet oncology treatment demands.

Raw Material/Component Suppliers — supply precision-engineered parts and materials for external beam radiotherapy systems

OEMs/Manufacturers — design and produce linear accelerators and radiation therapy devices

Technology Providers — develop software and AI solutions for treatment planning and dose calculation

System Integrators — implement and customize external beam radiotherapy systems for healthcare facilities

Distributors/Channel Partners — manage logistics and sales channels for equipment and accessories

Service Providers/After-Sales — deliver maintenance, repair, and technical support for installed systems

Regulators/Standards Bodies — oversee safety, efficacy, and compliance across the value chain analysis

Control points in the ecosystem reside with OEMs, regulators, and technology providers, which shape adoption through innovation, certification, and integration requirements. Dependency risks arise from specialized component suppliers and evolving regulatory frameworks. High switching costs for end users due to system interoperability needs and long-term service contracts reinforce partnerships between providers and healthcare institutions.

Recent Industry Insights

The external beam radiotherapy industry trends have witnessed significant momentum over the past 18 months, driven by technological innovation and strategic collaborations. Major players like Varian Medical Systems and Siemens Healthineers have formed partnerships to integrate AI-powered treatment planning into next-generation linear accelerators, enhancing precision in tumor targeting. Notably, Elekta launched the Unity MR-Linac system, which combines real-time MRI guidance with radiation delivery, marking a leap in adaptive radiotherapy. Regulatory agencies, including the FDA, have expedited approvals for hypofractionated regimens, enabling shorter treatment courses for lung and prostate cancers. Meanwhile, consumer demand is shifting toward personalized therapies, with proton therapy adoption rising due to improved outcomes in pediatric and complex oncology cases.

Key developments in M&A and funding3 items

Accuray Incorporated acquired by Elekta in 2023 to strengthen stereotactic body radiotherapy (SBRT) capabilities.

Proton Therapy Centers (PTC) secured $50M in Series C funding to expand U.S. proton therapy infrastructure.

Varian Medical Systems partnered with NVIDIA to develop AI-driven dose optimization tools for radiation oncology.

Emerging enterprise trends highlight a push toward decentralized care models, with mobile external beam radiotherapy units addressing rural access gaps. Additionally, the industry is prioritizing carbon-ion therapy R&D, with Japan and Germany leading clinical trials. As AI and machine learning permeate treatment workflows, the external beam radiotherapy industry trends are poised for transformative growth, supported by regulatory tailwinds and rising investment in precision oncology.

Analyst Overview

The external beam radiotherapy market exhibits strong market attractiveness due to rising cancer prevalence, technological advancements, and growing demand for non-invasive treatment options. Competitive intensity remains moderate, with established players focusing on product differentiation through precision technologies and strategic partnerships. The long-term outlook is optimistic, driven by aging populations, expanding healthcare access in emerging economies, and increasing adoption of proton therapy. The innovation landscape is dynamic, with AI-integrated treatment planning and real-time adaptive radiotherapy gaining traction. However, a cautious demand–supply balance persists, as infrastructure gaps in low-resource regions offset growth in mature markets. Key risk factors include stringent regulatory scrutiny, high treatment costs, and reimbursement challenges. Stakeholders should prioritize R&D in cost-effective solutions to capitalize on the external beam radiotherapy market outlook.

12 items

1. Executive Summary

2. external beam radiotherapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global external beam radiotherapy Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global external beam radiotherapy Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global external beam radiotherapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global external beam radiotherapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global external beam radiotherapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global external beam radiotherapy Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global external beam radiotherapy Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global external beam radiotherapy Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global external beam radiotherapy Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global external beam radiotherapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global external beam radiotherapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global external beam radiotherapy Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global external beam radiotherapy Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global external beam radiotherapy Market Competition by Key Manufacturers

9.1. Global external beam radiotherapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global external beam radiotherapy: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Varian Medical Systems, Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Elekta AB

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Accuray Incorporated

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ion Beam Applications (IBA)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nordion, Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. C. R. Bard, Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global external beam radiotherapy Market

Figure 4: Global external beam radiotherapy Market: Drivers

Figure 5: Global external beam radiotherapy Market: Challenges

Figure 6: Global external beam radiotherapy Market: Trends

Figure 7: Global external beam radiotherapy Market: Opportunity

Figure 8: Global external beam radiotherapy Market: Restraint

Figure 9: Global external beam radiotherapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global external beam radiotherapy Market Value (USD Million) By Region

Figure 19: Global external beam radiotherapy Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global external beam radiotherapy Market Value (USD Million) By Region

Figure 27: Global external beam radiotherapy Market Share (%) By: Regions (2032)

Figure 28: Global external beam radiotherapy Market Volume (K) By Region

Figure 29: Global external beam radiotherapy Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global external beam radiotherapy Market Value (USD Million) By Region

Figure 37: Global external beam radiotherapy Market Share (%) By: Regions (2032)

Figure 38: Global external beam radiotherapy Market Volume (K) By Region

Figure 39: Global external beam radiotherapy Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global external beam radiotherapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global external beam radiotherapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global external beam radiotherapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global external beam radiotherapy Market Value (USD Million) By Region

Table 14: Global external beam radiotherapy Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global external beam radiotherapy Market Volume (K) By Region

Table 31: Global external beam radiotherapy Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global external beam radiotherapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global external beam radiotherapy Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global external beam radiotherapy Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Varian Medical Systems, Inc. Basic Information And Sales Area

Table 52: Varian Medical Systems, Inc.. Products Portfolio

Table 53: Elekta AB Basic Information And Sales Area

Table 54: Elekta AB. Products Portfolio

Table 55: Accuray Incorporated Basic Information And Sales Area

Table 56: Accuray Incorporated. Products Portfolio

Table 57: Ion Beam Applications (IBA) Basic Information And Sales Area

Table 58: Ion Beam Applications (IBA). Products Portfolio

Table 59: Nordion, Inc. Basic Information And Sales Area

Table 60: Nordion, Inc.. Products Portfolio

Table 61: C. R. Bard, Inc. Basic Information And Sales Area

Table 62: C. R. Bard, Inc.. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global external beam radiotherapy Market Value (USD Million) By Region

Table 72: Global external beam radiotherapy Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global external beam radiotherapy Market Volume (K) By Region

Table 89: Global external beam radiotherapy Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

external beam radiotherapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Varian Medical Systems, Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications (IBA); Nordion, Inc.; C. R. Bard, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory frameworks and prolonged approval timelines across regions create market entry barriers, delaying innovation cycles and increasing compliance costs for manufacturers.

Opportunities2 items

Expansion into Asia-Pacific and Latin America offers significant growth potential, driven by improving healthcare infrastructure and rising insurance penetration in these untapped markets.

Challenges2 items

Reimbursement disparities across geographies, particularly in the U.S. and EU, risk limiting access to advanced therapies despite their clinical advantages.

Shortage of trained radiation oncologists and medical physicists is constraining treatment capacity, especially in rural and low-resource settings, hampering market scalability.

Market Segmentation

Loading chart…

external beam radiotherapy Segmentation Breakdown12 items

Application

Hospitals

Ambulatory Radiotherapy Centers

Cancer Research Institutes

Types

Intensity-modulated Radiotherapy (IMRT)

Image-guided Radiotherapy (IGRT)

TomoTherapy

Stereotactic Therapy

3D Conformal Radiotherapy

Particle Beam Therapy

Volumetric Modulated Arc Therapy

Regional Insights

Loading chart…

Competitive Landscape

Varian Medical Systems, Inc. — M&A-driven expansion

Elekta AB — Strategic OEM partnerships for linear accelerators

Accuray Incorporated — Innovation pipeline in stereotactic radiosurgery

Ion Beam Applications (IBA) — Niche proton therapy market focus

Nordion, Inc. — Radioisotope supply chain vertical integration

C. R. Bard, Inc. — Cost-competitive portfolio for emerging markets

Key external beam radiotherapy Companies6 items

Varian Medical Systems, Inc.

Elekta AB

Accuray Incorporated

Ion Beam Applications (IBA)

Nordion, Inc.

C. R. Bard, Inc.

Market Ecosystem

Raw Material/Component Suppliers — supply precision-engineered parts and materials for external beam radiotherapy systems

OEMs/Manufacturers — design and produce linear accelerators and radiation therapy devices

Technology Providers — develop software and AI solutions for treatment planning and dose calculation

System Integrators — implement and customize external beam radiotherapy systems for healthcare facilities

Distributors/Channel Partners — manage logistics and sales channels for equipment and accessories

Service Providers/After-Sales — deliver maintenance, repair, and technical support for installed systems

Regulators/Standards Bodies — oversee safety, efficacy, and compliance across the value chain analysis

Recent Industry Insights

Key developments in M&A and funding3 items

Accuray Incorporated acquired by Elekta in 2023 to strengthen stereotactic body radiotherapy (SBRT) capabilities.

Proton Therapy Centers (PTC) secured $50M in Series C funding to expand U.S. proton therapy infrastructure.

Varian Medical Systems partnered with NVIDIA to develop AI-driven dose optimization tools for radiation oncology.

Analyst Overview

Table of Contents